Gallardo, Analyn C.

HRN: 02-63-32  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2024
CEFUROXIME 750MG (VIAL)
08/06/2024
08/13/2024
IV
750mg
Q12
T/C Urosepsis
Rejected 

 Indication:  Empiric    Type of Infection:  Urinary TractBloodstream    Compliance to guidelines: Guideline Not Available